Myocardial infarction (MI) and end‐stage heart failure represent some of the major life‐threatening pathologies. Current conventional treatments of the aftermath of MI involve promoting revascularization to protect residual cells and slowing down the progression of heart failure. However, these treatment modalities fail to restore the ability of the heart to provide adequate blood supply. In spite of promising preclinical results, most clinical trials have shown that the long‐term outcome of cellbased therapies does not exceed that of conventional pharmacological intervention. For end‐stage patients, heart transplantation is the only alternative, which remains limited due to the shortage of donor organs and to the potential for rejection of...
Cardiac patches consisting of induced pluripotent stem cell‐derived cardiomyocytes (iPSC‐CMs) show b...
By-pass surgery and heart transplantation are traditionally used to restore the heart’s functionalit...
Nanofibrous scaffolds with defined architectures and anisotropic mechanical properties are attractiv...
© 2021 The Textile Institute.Cardiac patch has been proposed as an alternative therapeutic tissue en...
Nature has had millions of years to perfect the structural components of the human body, but has als...
Heart failure (HF) is a leading cause of death worldwide. The most common conditions that lead to HF...
Cardiac cell therapy holds a real promise for improving heart function and especially of the chronic...
Heart failure (HF) is a leading cause of death worldwide. The most common conditions that lead to HF...
Current limitations in cardiac tissue engineering revolve around the inability to fully recapitulate...
International audienceCardiac cell therapy holds a real promise for improving heart function and esp...
Cardiac patches consisting of induced pluripotent stem cell‐derived cardiomyocytes (iPSC‐CMs) show b...
By-pass surgery and heart transplantation are traditionally used to restore the heart’s functionalit...
Nanofibrous scaffolds with defined architectures and anisotropic mechanical properties are attractiv...
© 2021 The Textile Institute.Cardiac patch has been proposed as an alternative therapeutic tissue en...
Nature has had millions of years to perfect the structural components of the human body, but has als...
Heart failure (HF) is a leading cause of death worldwide. The most common conditions that lead to HF...
Cardiac cell therapy holds a real promise for improving heart function and especially of the chronic...
Heart failure (HF) is a leading cause of death worldwide. The most common conditions that lead to HF...
Current limitations in cardiac tissue engineering revolve around the inability to fully recapitulate...
International audienceCardiac cell therapy holds a real promise for improving heart function and esp...
Cardiac patches consisting of induced pluripotent stem cell‐derived cardiomyocytes (iPSC‐CMs) show b...
By-pass surgery and heart transplantation are traditionally used to restore the heart’s functionalit...
Nanofibrous scaffolds with defined architectures and anisotropic mechanical properties are attractiv...